From: Dislodgement of port-A catheters in pediatric oncology patients: 11 years of experience
Without | With | P value | |
---|---|---|---|
dislodgement | dislodgement | ||
(N = 322) | (N = 8) | ||
Age at insertion (months) | 90.2 ± 3.5 | 82.4 ± 12.5 | 0.565 |
Sex (number) (M:F)a | 189 : 133 | 3 : 5 | 0.402 |
Duration of use (months) | 33.9 ± 1.2 | 32.1 ± 5.0 | 0.818 |
Diagnosis | 0.089 | ||
ALL | 152 | 2 | |
AML | 28 | 2 | |
Lymphoma | 37 | 1 | |
Brain tumor | 24 | 0 | |
Soft tissue sarcoma | 15 | 2 | |
Other | 66 | 1 | |
Port-A brand | 0.006b | ||
Vortex | 134 | 1 | |
Bard | 151 | 3 | |
Arrow | 16 | 3 | |
Other | 21 | 1 | |
Laterality (R:L)a | 248:74 | 6:2 | 1 |
Vein inserted | |||
Internal jugular | 241 | 4 | 0.286 |
External jugular | 29 | 1 | |
Subclavian | 48 | 3 | |
Other | 4 | 0 | |
Operator | 0.843 | ||
A | 181 | 4 | |
B | 122 | 4 | |
C | 14 | 0 | |
D | 5 | 0 |